G V I C l i e n t s

M i r a c u l i n s I n c .
Miraculins is a medical diagnostic company focused on developing non-invasive tests for unmet clinical needs. The Company’s PreVu test is a revolutionary new coronary artery disease (CAD) risk assessment technology that measures cholesterol levels in a patient’s skin non-invasively, painlessly and without the need for fasting. The Company’s preeclampsia program is being advanced in partnership with Alere, Inc. (NYSE:ALR) (formerly known as Inverness Medical Innovations), one of the world’s largest diagnostic companies.

K a n e B i o t e c h I n c .
Kane Biotech Inc. is a publicly traded biotechnology company established around a patent protected technology to find compounds which prevent or disrupt biofilms in medical and industrial applications. The Company has three technology platforms and Kane Biotech’s two lead market areas are medical device coatings and wound care products.

M e d i c u r e I n c .
Medicure is a specialty pharmaceutical company established in 1997. The Company’s vision is to become a leading specialty pharmaceutical company in the commercialization and development of unique small molecule pharmaceuticals in the cardiovascular and neurological fields for unmet medical needs.

G V I C l i n i c a l D e v e l o p m e n t S o l u t i o n s I n c .
GVI Clinical Development Solutions is an innovative contract research organization that provides hands-on clinical and regulatory support to biotechnology, pharmaceutical, diagnostic, nutraceutical and medical device companies.

C A N A M B i o r e s e a r c h I n c .
CanAm Bioresearch is a well-established pharmaceutical contract research organization specializing in pre-clinical discovery and development. The company provides bioanalytical, pharmacokinetic, pharmacology, and custom chemical synthesis services.

K A M S c i e n t i f i c I n c .
KAM Scientific is the manufacturer and distributor of Virocidin-X, a potent, ready-to-use microbial disinfectant spray solution. KAM Scientific's primary focus is the marketing and distribution of novel scientific products for commercial use.

P a s t C l i e n t s

	D i a m e d i c a I n c . Diamedica Inc. is a biopharmaceutical company focused on developing unique pharmacologic therapies for type 2 diabetes. DM-71, the Company’s most clinically advanced product, may be able to reduce blood sugar and weight in people diagnosed with type 2 diabetes, as shown in an early phase IIa clinical trial.

	S a n o m u n e I n c . Sanomune is a product focused biopharmaceutical company oriented towards therapeutic regulation of the immune system. The company has identified a naturally-occurring protein with applications as a therapy for Alzheimer’s, Autoimmune diseases and several additional indications.

	M a n t e x B i o t e c h I n c . Mantex was established in 1997 to develop effective treatments for cardiac hypertrophy and heart failure. In 1999, Mantex's technology was sold to the US biotechnology firm Myogen Inc, and has recently been bought out by Gillead Sciences, Inc. (NASDAQ:GILD), the world’s third largest biotech company.